Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine + propofol dosing and safety for painless gastrointestinal endoscopy
ChiCTR2300069846Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Shantou University Medical College
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in None (4 arms), sponsored by The Second Affiliated Hospital of Shantou University Medical College. Primary endpoints: heart rate, blood pressure and 2 more. Started Apr 2023; status: recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2300069846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069846.